{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:02:37Z","timestamp":1789506157298,"version":"build-2803163510"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T00:00:00Z","timestamp":1615852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100016667","name":"Sean N. Parker Center for Allergy and Asthma Research at Stanford University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100016667","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Allergy Asthma Clin Immunol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Atopic diseases, such as atopic dermatitis (AD) and food allergy (FA), have increased in prevalence in industrialized countries during the past few decades and pose a significant health burden. They appear to have a common underlying mechanism and a natural disease progression. AD is generally the first atopic disease to manifest followed by other atopic diseases, such as FA, allergic rhinitis, or allergic asthma suggesting that they are likely different manifestations of the same disease.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Body<\/jats:title>\n                <jats:p>Evidence suggests that allergic sensitization occurs through an impaired skin barrier, while consumption of these foods at an early age may actually result in tolerance. This has been termed the Dual-Allergen-Exposure hypothesis. Loss of barrier integrity has been hypothesized to enable penetration of allergens, pollutants, and microbes and initiation of an inflammatory immune cascade of events leading to sensitization. The immune dysfunction is thought to further exacerbate the impaired skin barrier to form a vicious cycle. There is much interest in preventing or protecting the skin barrier from developing a proinflammatory atopic state, which may potentially lead to the development of AD and subsequently, FA.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Research on preventing or treating skin barrier dysfunction is ongoing. A number of studies have evaluated the efficacy of emollients in preventing AD and FA with mixed results. Studies have differed in the study design, population characteristics, emollients type, and frequency, duration, and area of application. Emollient type has varied widely from oils, creams, petrolatum-based lotions, and trilipid creams. Current research is directed towards the use of trilipid emollients that are similar to the skin\u2019s natural lipid composition with a 3:1:1 ratio of ceramides, cholesterol and free fatty acids and a pH that is similar to that of skin to determine their effectiveness for skin barrier repair and prevention of AD and FA.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13223-021-00531-8","type":"journal-article","created":{"date-parts":[[2021,3,16]],"date-time":"2021-03-16T09:07:48Z","timestamp":1615885668000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Early intervention of atopic dermatitis as a preventive strategy for progression of food allergy"],"prefix":"10.1186","volume":"17","author":[{"given":"Alyssa","family":"Sweeney","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanitha","family":"Sampath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2146-2955","authenticated-orcid":false,"given":"Kari C.","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,3,16]]},"reference":[{"key":"531_CR1","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.det.2017.02.002","volume":"35","author":"JI Silverberg","year":"2017","unstructured":"Silverberg JI. Public health burden and epidemiology of atopic dermatitis. Dermatol Clin. 2017;35:283\u20139.","journal-title":"Dermatol Clin"},{"key":"531_CR2","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1016\/j.jaip.2017.10.024","volume":"6","author":"AM Drucker","year":"2018","unstructured":"Drucker AM, Qureshi AA, Amand C, et al. Health care resource utilization and costs among adults with atopic dermatitis in the United States: a claims-based analysis. J Allergy Clin Immunol Pract. 2018;6:1342\u20138.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"531_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.23736\/S0392-0488.19.06430-7","volume":"155","author":"P Sciattella","year":"2020","unstructured":"Sciattella P, Pellacani G, Pigatto PD, et al. The burden of atopic dermatitis in adults in Italy. G Ital Dermatol Venereol. 2020;155:19\u201323.","journal-title":"G Ital Dermatol Venereol"},{"key":"531_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s11882-020-0898-7","volume":"20","author":"CM Warren","year":"2020","unstructured":"Warren CM, Jiang J, Gupta RS. Epidemiology and burden of food allergy. Curr Allergy Asthma Rep. 2020;20:6.","journal-title":"Curr Allergy Asthma Rep"},{"key":"531_CR5","first-page":"S28","volume":"144","author":"RS Gupta","year":"2018","unstructured":"Gupta RS, Warren CM, Smith BM, et al. The public health impact of parent-reported childhood food allergies in the United States. Pediatrics. 2018;144:S28.","journal-title":"Pediatrics"},{"key":"531_CR6","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1111\/pai.12908","volume":"29","author":"MS Motosue","year":"2018","unstructured":"Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Campbell RL. National trends in emergency department visits and hospitalizations for food-induced anaphylaxis in US children. Pediatr Allergy Immunol. 2018;29:538\u201344.","journal-title":"Pediatr Allergy Immunol"},{"key":"531_CR7","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jaip.2012.11.005","volume":"1","author":"MM Bergmann","year":"2013","unstructured":"Bergmann MM, Caubet JC, Boguniewicz M, Eigenmann PA. Evaluation of food allergy in patients with atopic dermatitis. J Allergy Clin Immunol Pract. 2013;1:22\u20138.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"531_CR8","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.jaip.2018.10.043","volume":"7","author":"C Venter","year":"2019","unstructured":"Venter C, Sicherer SH, Greenhawt M. Management of peanut allergy. J Allergy Clin Immunol Pract. 2019;7:345\u201355.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"531_CR9","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1067\/mai.2001.112129","volume":"107","author":"HS Skolnick","year":"2001","unstructured":"Skolnick HS, Conover-Walker MK, Koerner CB, Sampson HA, Burks W, Wood RA. The natural history of peanut allergy. J Allergy Clin Immunol. 2001;107:367\u201374.","journal-title":"J Allergy Clin Immunol"},{"key":"531_CR10","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1080\/1744666X.2019.1641406","volume":"15","author":"LA Scott","year":"2019","unstructured":"Scott LA, Berni TR, Berni ER, De Vries J, Currie CJ. Evaluation of the healthcare resource use and the related financial costs of managing peanut allergy in the United Kingdom. Expert Rev Clin Immunol. 2019;15:889\u201396.","journal-title":"Expert Rev Clin Immunol"},{"key":"531_CR11","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1001\/jamapediatrics.2013.2376","volume":"167","author":"R Gupta","year":"2013","unstructured":"Gupta R, Holdford D, Bilaver L, Dyer A, Holl JL, Meltzer D. The economic impact of childhood food allergy in the United States. JAMA Pediatr. 2013;167:1026\u201331.","journal-title":"JAMA Pediatr"},{"key":"531_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.anai.2017.10.037","volume":"120","author":"DA Hill","year":"2018","unstructured":"Hill DA, Spergel JM. The atopic march: critical evidence and clinical relevance. Ann Allergy Asthma Immunol. 2018;120:131\u20137.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"531_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/cea.12406","volume":"45","author":"PE Martin","year":"2015","unstructured":"Martin PE, Eckert JK, Koplin JJ, et al. Which infants with eczema are at risk of food allergy? Results from a population-based cohort. Clin Exp Allergy. 2015;45:255\u201364.","journal-title":"Clin Exp Allergy"},{"key":"531_CR14","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.anai.2017.11.023","volume":"120","author":"AJ Lowe","year":"2018","unstructured":"Lowe AJ, Leung DYM, Tang MLK, Su JC, Allen KJ. The skin as a target for prevention of the atopic march. Ann Allergy Asthma Immunol. 2018;120:145\u201351.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"531_CR15","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1111\/bjd.16934","volume":"180","author":"T Tsakok","year":"2019","unstructured":"Tsakok T, Woolf R, Smith CH, Weidinger S, Flohr C. Atopic dermatitis: the skin barrier and beyond. Br J Dermatol. 2019;180:464\u201374.","journal-title":"Br J Dermatol"},{"key":"531_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.immuni.2015.07.007","volume":"43","author":"H Hammad","year":"2015","unstructured":"Hammad H, Lambrecht BN. Barrier epithelial cells and the control of type 2 immunity. Immunity. 2015;43:29\u201340.","journal-title":"Immunity"},{"key":"531_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jaci.2017.11.003","volume":"141","author":"SH Sicherer","year":"2018","unstructured":"Sicherer SH, Sampson HA. Food allergy: a review and update on epidemiology, pathogenesis, diagnosis, prevention, and management. J Allergy Clin Immunol. 2018;141:41\u201358.","journal-title":"J Allergy Clin Immunol"},{"key":"531_CR18","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/all.12268","volume":"69","author":"SC Dharmage","year":"2014","unstructured":"Dharmage SC, Lowe AJ, Matheson MC, Burgess JA, Allen KJ, Abramson MJ. Atopic dermatitis and the atopic march revisited. Allergy. 2014;69:17\u201327.","journal-title":"Allergy"},{"key":"531_CR19","doi-asserted-by":"publisher","first-page":"1614","DOI":"10.1172\/JCI1647","volume":"101","author":"JM Spergel","year":"1998","unstructured":"Spergel JM, Mizoguchi E, Brewer JP, Martin TR, Bhan AK, Geha RS. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest. 1998;101:1614\u201322.","journal-title":"J Clin Invest"},{"key":"531_CR20","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000497382","volume":"179","author":"S Benor","year":"2019","unstructured":"Benor S, Shani N, Etkin S, Bondar E, Kivity S, Langier S. Epicutaneous exposure to peanut oil induces systemic and pulmonary allergic reaction in mice. Int Arch Allergy Immunol. 2019;179:187\u201391.","journal-title":"Int Arch Allergy Immunol"},{"key":"531_CR21","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.jaci.2015.12.1312","volume":"137","author":"MM Kelleher","year":"2016","unstructured":"Kelleher MM, Dunn-Galvin A, Gray C, et al. Skin barrier impairment at birth predicts food allergy at 2 years of age. J Allergy Clin Immunol. 2016;137:1111\u20136.","journal-title":"J Allergy Clin Immunol"},{"key":"531_CR22","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jaci.2013.02.034","volume":"132","author":"HA Brough","year":"2013","unstructured":"Brough HA, Santos AF, Makinson K, et al. Peanut protein in household dust is related to household peanut consumption and is biologically active. J Allergy Clin Immunol. 2013;132:630\u20138.","journal-title":"J Allergy Clin Immunol"},{"key":"531_CR23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jaci.2014.08.011","volume":"134","author":"HA Brough","year":"2014","unstructured":"Brough HA, Simpson A, Makinson K, et al. Peanut allergy: effect of environmental peanut exposure in children with filaggrin loss-of-function mutations. J Allergy Clin Immunol. 2014;134:867\u201375.","journal-title":"J Allergy Clin Immunol"},{"key":"531_CR24","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.jaci.2014.10.007","volume":"135","author":"HA Brough","year":"2015","unstructured":"Brough HA, Liu AH, Sicherer S, et al. Atopic dermatitis increases the effect of exposure to peanut antigen in dust on peanut sensitization and likely peanut allergy. J Allergy Clin Immunol. 2015;135:164\u201370.","journal-title":"J Allergy Clin Immunol"},{"key":"531_CR25","doi-asserted-by":"crossref","unstructured":"Lack G, Fox D, Northstone K, Golding J, Avon Longitudinal Study of P, Children Study T. Factors associated with the development of peanut allergy in childhood. N Engl J Med. 2003;348:977\u201385.","DOI":"10.1056\/NEJMoa013536"},{"key":"531_CR26","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1159\/000500402","volume":"235","author":"M Loset","year":"2019","unstructured":"Loset M, Brown SJ, Saunes M, Hveem K. Genetics of atopic dermatitis: from DNA sequence to clinical relevance. Dermatology. 2019;235:355\u201364.","journal-title":"Dermatology"},{"key":"531_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41572-018-0001-z","volume":"4","author":"S Weidinger","year":"2018","unstructured":"Weidinger S, Beck LA, Bieber T, Kabashima K, Irvine AD. Atopic dermatitis. Nat Rev Dis Primers. 2018;4:1.","journal-title":"Nat Rev Dis Primers"},{"key":"531_CR28","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1056\/NEJMra1011040","volume":"365","author":"AD Irvine","year":"2011","unstructured":"Irvine AD, McLean WH, Leung DY. Filaggrin mutations associated with skin and allergic diseases. N Engl J Med. 2011;365:1315\u201327.","journal-title":"N Engl J Med"},{"key":"531_CR29","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1111\/j.1365-2133.2010.10068.x","volume":"163","author":"C Flohr","year":"2010","unstructured":"Flohr C, England K, Radulovic S, et al. Filaggrin loss-of-function mutations are associated with early-onset eczema, eczema severity and transepidermal water loss at 3 months of age. Br J Dermatol. 2010;163:1333\u20136.","journal-title":"Br J Dermatol"},{"key":"531_CR30","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/978-981-15-3449-2_4","volume":"1253","author":"Z Mu","year":"2020","unstructured":"Mu Z, Zhang J. The role of genetics, the environment, and epigenetics in atopic dermatitis. Adv Exp Med Biol. 2020;1253:107\u201340.","journal-title":"Adv Exp Med Biol"},{"key":"531_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00394-018-1703-4","volume":"57","author":"MH Mohajeri","year":"2018","unstructured":"Mohajeri MH, Brummer RJM, Rastall RA, et al. The role of the microbiome for human health: from basic science to clinical applications. Eur J Nutr. 2018;57:1\u201314.","journal-title":"Eur J Nutr"},{"key":"531_CR32","doi-asserted-by":"crossref","unstructured":"Patella V, Florio G, Palmieri M, et al. Atopic Dermatitis Severity during Exposure to Air Pollutants and Weather Changes with an artificial neural network (ANN) analysis. Pediatr Allergy Immunol. 2020.","DOI":"10.1111\/pai.13314"},{"key":"531_CR33","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.envres.2017.10.030","volume":"160","author":"I Oh","year":"2018","unstructured":"Oh I, Lee J, Ahn K, et al. Association between particulate matter concentration and symptoms of atopic dermatitis in children living in an industrial urban area of South Korea. Environ Res. 2018;160:462\u20138.","journal-title":"Environ Res"},{"key":"531_CR34","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12940-020-0563-6","volume":"19","author":"KD Min","year":"2020","unstructured":"Min KD, Yi SJ, Kim HC, et al. Association between exposure to traffic-related air pollution and pediatric allergic diseases based on modeled air pollution concentrations and traffic measures in Seoul, Korea: a comparative analysis. Environ Health. 2020;19:6.","journal-title":"Environ Health"},{"key":"531_CR35","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1159\/000094670","volume":"19","author":"MH Schmid-Wendtner","year":"2006","unstructured":"Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol. 2006;19:296\u2013302.","journal-title":"Skin Pharmacol Physiol"},{"key":"531_CR36","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1038\/jid.2009.133","volume":"129","author":"MJ Cork","year":"2009","unstructured":"Cork MJ, Danby SG, Vasilopoulos Y, et al. Epidermal barrier dysfunction in atopic dermatitis. J Invest Dermatol. 2009;129:1892\u2013908.","journal-title":"J Invest Dermatol"},{"key":"531_CR37","doi-asserted-by":"publisher","first-page":"137","DOI":"10.4168\/aair.2020.12.1.137","volume":"12","author":"HJ Kim","year":"2020","unstructured":"Kim HJ, Lee SH, Hong SJ. Antibiotics-induced dysbiosis of intestinal microbiota aggravates atopic dermatitis in mice by altered short-chain fatty acids. Allergy Asthma Immunol Res. 2020;12:137\u201348.","journal-title":"Allergy Asthma Immunol Res"},{"key":"531_CR38","doi-asserted-by":"publisher","first-page":"e180315","DOI":"10.1001\/jamapediatrics.2018.0315","volume":"172","author":"E Mitre","year":"2018","unstructured":"Mitre E, Susi A, Kropp LE, Schwartz DJ, Gorman GH, Nylund CM. Association between use of acid-suppressive medications and antibiotics during infancy and allergic diseases in early childhood. JAMA Pediatr. 2018;172:e180315.","journal-title":"JAMA Pediatr"},{"key":"531_CR39","doi-asserted-by":"publisher","first-page":"145","DOI":"10.3345\/kjp.2017.60.5.145","volume":"60","author":"SH Lee","year":"2017","unstructured":"Lee SH, Gong YN, Ryoo E. Clostridium difficile colonization and\/or infection during infancy and the risk of childhood allergic diseases. Korean J Pediatr. 2017;60:145\u201350.","journal-title":"Korean J Pediatr"},{"key":"531_CR40","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.coi.2020.02.007","volume":"66","author":"K Ahn","year":"2020","unstructured":"Ahn K, Kim BE, Kim J, Leung DY. Recent advances in atopic dermatitis. Curr Opin Immunol. 2020;66:14\u201321.","journal-title":"Curr Opin Immunol"},{"key":"531_CR41","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1067\/mpd.2000.109376","volume":"137","author":"TK Vander Leek","year":"2000","unstructured":"Vander Leek TK, Liu AH, Stefanski K, Blacker B, Bock SA. The natural history of peanut allergy in young children and its association with serum peanut-specific IgE. J Pediatr. 2000;137:749\u201355.","journal-title":"J Pediatr"},{"key":"531_CR42","doi-asserted-by":"publisher","first-page":"1662","DOI":"10.1542\/peds.111.S3.1662","volume":"111","author":"RS Zeiger","year":"2003","unstructured":"Zeiger RS. Food allergen avoidance in the prevention of food allergy in infants and children. Pediatrics. 2003;111:1662\u201371.","journal-title":"Pediatrics"},{"key":"531_CR43","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1056\/NEJMoa1414850","volume":"372","author":"G Du Toit","year":"2015","unstructured":"Du Toit G, Roberts G, Sayre PH, et al. Randomized trial of peanut consumption in infants at risk for peanut allergy. N Engl J Med. 2015;372:803\u201313.","journal-title":"N Engl J Med"},{"key":"531_CR44","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1056\/NEJMoa1514210","volume":"374","author":"MR Perkin","year":"2016","unstructured":"Perkin MR, Logan K, Tseng A, et al. Randomized trial of introduction of allergenic foods in breast-fed infants. N Engl J Med. 2016;374:1733\u201343.","journal-title":"N Engl J Med"},{"key":"531_CR45","doi-asserted-by":"crossref","unstructured":"NIAID-Sponsored Expert Panel, Boyce JA, Assa\u2019ad A, et al. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J Allergy Clin Immunol. 2010;126:S1\u201358.","DOI":"10.1016\/j.jaci.2010.10.007"},{"key":"531_CR46","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1016\/j.jaci.2019.06.045","volume":"144","author":"MR Perkin","year":"2019","unstructured":"Perkin MR, Logan K, Bahnson HT, et al. Efficacy of the Enquiring About Tolerance (EAT) study among infants at high risk of developing food allergy. J Allergy Clin Immunol. 2019;144:1606\u201314.","journal-title":"J Allergy Clin Immunol"},{"key":"531_CR47","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1016\/j.jaci.2019.09.004","volume":"144","author":"P Voorheis","year":"2019","unstructured":"Voorheis P, Bell S, Cornelsen L, et al. Challenges experienced with early introduction and sustained consumption of allergenic foods in the Enquiring About Tolerance (EAT) study: a qualitative analysis. J Allergy Clin Immunol. 2019;144:1615\u201323.","journal-title":"J Allergy Clin Immunol"},{"key":"531_CR48","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.anai.2018.06.008","volume":"121","author":"HR Fisher","year":"2018","unstructured":"Fisher HR, Du Toit G, Bahnson HT, Lack G. The challenges of preventing food allergy: lessons learned from LEAP and EAT. Ann Allergy Asthma Immunol. 2018;121:313\u20139.","journal-title":"Ann Allergy Asthma Immunol"},{"key":"531_CR49","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jaci.2014.12.013","volume":"135","author":"M Kelleher","year":"2015","unstructured":"Kelleher M, Dunn-Galvin A, Hourihane JO, et al. Skin barrier dysfunction measured by transepidermal water loss at 2 days and 2 months predates and predicts atopic dermatitis at 1 year. J Allergy Clin Immunol. 2015;135:930\u20135.","journal-title":"J Allergy Clin Immunol"},{"key":"531_CR50","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.jaci.2014.08.005","volume":"134","author":"EL Simpson","year":"2014","unstructured":"Simpson EL, Chalmers JR, Hanifin JM, et al. Emollient enhancement of the skin barrier from birth offers effective atopic dermatitis prevention. J Allergy Clin Immunol. 2014;134:818\u201323.","journal-title":"J Allergy Clin Immunol"},{"key":"531_CR51","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1016\/j.jaci.2014.07.060","volume":"134","author":"K Horimukai","year":"2014","unstructured":"Horimukai K, Morita K, Narita M, et al. Application of moisturizer to neonates prevents development of atopic dermatitis. J Allergy Clin Immunol. 2014;134:824\u201330.","journal-title":"J Allergy Clin Immunol"},{"key":"531_CR52","doi-asserted-by":"publisher","first-page":"e19","DOI":"10.1111\/bjd.15747","volume":"178","author":"AJ Lowe","year":"2018","unstructured":"Lowe AJ, Su JC, Allen KJ, et al. A randomized trial of a barrier lipid replacement strategy for the prevention of atopic dermatitis and allergic sensitization: the PEBBLES pilot study. Br J Dermatol. 2018;178:e19\u201321.","journal-title":"Br J Dermatol"},{"key":"531_CR53","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1111\/jdv.15786","volume":"33","author":"D McClanahan","year":"2019","unstructured":"McClanahan D, Wong A, Kezic S, et al. A randomized controlled trial of an emollient with ceramide and filaggrin-associated amino acids for the primary prevention of atopic dermatitis in high-risk infants. J Eur Acad Dermatol Venereol. 2019;33:2087\u201394.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"531_CR54","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1159\/000501636","volume":"180","author":"E Dissanayake","year":"2019","unstructured":"Dissanayake E, Tani Y, Nagai K, et al. Skin Care and Synbiotics for Prevention of Atopic Dermatitis or Food Allergy in Newborn Infants: A 2 x 2 Factorial, Randomized, Non-Treatment Controlled Trial. Int Arch Allergy Immunol. 2019;180:202\u201311.","journal-title":"Int Arch Allergy Immunol"},{"key":"531_CR55","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/S0140-6736(19)32984-8","volume":"395","author":"JR Chalmers","year":"2020","unstructured":"Chalmers JR, Haines RH, Bradshaw LE, et al. Daily emollient during infancy for prevention of eczema: the BEEP randomised controlled trial. Lancet. 2020;395:962\u201372.","journal-title":"Lancet"},{"key":"531_CR56","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/S0140-6736(19)32983-6","volume":"395","author":"HO Skjerven","year":"2020","unstructured":"Skjerven HO, Rehbinder EM, Vettukattil R, et al. Skin emollient and early complementary feeding to prevent infant atopic dermatitis (PreventADALL): a factorial, multicentre, cluster-randomised trial. Lancet. 2020;395:951\u201361.","journal-title":"Lancet"},{"key":"531_CR57","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1111\/1523-1747.ep12340135","volume":"106","author":"MM Man","year":"1996","unstructured":"Man MM, Feingold KR, Thornfeldt CR, Elias PM. Optimization of physiological lipid mixtures for barrier repair. J Invest Dermatol. 1996;106:1096\u2013101.","journal-title":"J Invest Dermatol"},{"key":"531_CR58","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.dsi.2015.03.010","volume":"33","author":"G Man","year":"2015","unstructured":"Man G, Cheung C, Crumrine D, et al. An optimized inexpensive emollient mixture improves barrier repair in murine skin. Dermatol Sin. 2015;33:96\u2013102.","journal-title":"Dermatol Sin"},{"key":"531_CR59","doi-asserted-by":"crossref","unstructured":"Mao-Qiang M, Brown BE, Wu-Pong S, Feingold KR, Elias PM. Exogenous nonphysiologic vs physiologic lipids. Divergent mechanisms for correction of permeability barrier dysfunction. Arch Dermatol. 1995;131:809\u201316.","DOI":"10.1001\/archderm.131.7.809"},{"key":"531_CR60","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/1346-8138.14080","volume":"45","author":"K Yonezawa","year":"2018","unstructured":"Yonezawa K, Haruna M, Matsuzaki M, Shiraishi M, Kojima R. Effects of moisturizing skincare on skin barrier function and the prevention of skin problems in 3-month-old infants: a randomized controlled trial. J Dermatol. 2018;45:24\u201330.","journal-title":"J Dermatol"}],"container-title":["Allergy, Asthma &amp; Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-021-00531-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13223-021-00531-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13223-021-00531-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T02:07:44Z","timestamp":1675044464000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacijournal.biomedcentral.com\/articles\/10.1186\/s13223-021-00531-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,16]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["531"],"URL":"https:\/\/doi.org\/10.1186\/s13223-021-00531-8","relation":{},"ISSN":["1710-1492"],"issn-type":[{"value":"1710-1492","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,16]]},"assertion":[{"value":"1 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Nadeau reports grants from National Institute of Allergy and Infectious Diseases (NIAID), National Heart, Lung, and Blood Institute (NHLBI), and National Institute of Environmental Health Sciences (NIEHS); Food Allergy Research & Education (FARE), Director of World Allergy Organization (WAO) Center of Excellence at Stanford; Advisor at Cour Pharma; Co-founder of Before Brands, Alladapt, Latitude, and IgGenix; National Scientific Committee member at Immune Tolerance Network (ITN) and National Institutes of Health (NIH) clinical research centers; DSMB member for NHLBI, US patents for basophil testing, multifood immunotherapy and prevention, monoclonal antibody from plasmoblasts, and device for diagnostics. All other authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"30"}}